Navigation Links
Infinity Group Invests US$4.2 M in Green BioTech Company BotanoCap
Date:12/23/2013

BEIJING and TEL AVIV, Israel, December 23, 2013 /PRNewswire/ --

Infinity Group, a cross-border, private equity platform, announced today that it has invested US$4.2 M in green biotech company BotanoCap (http://www.botanocap.com). A little less than a quarter of the investment was made through a Chinese joint venture company established under the umbrella of the Infinity-Harbin fund. BotanoCap plans to use the financing for further business development in China, Europe and the United States, patent applications, maintenance and regulatory affair expenses.

Founded by professors from Ben Gurion University in 2005, BotanoCap develops green solutions intended to replace toxic chemical materials currently used by the agricultural, veterinary and household product industries. The company's novel technology creates modified release products based on natural ingredients. Applications include crop protection bio-pesticides, water treatment, natural disinfectants, anti-flea & tick for veterinary formulations and insect repellent, to name a few. 

"BotanoCap is helping the world go green, from every aspect of daily life - the food we eat, what we spray on ourselves and our pets as well as our cosmetics and house hold cleaning supplies. It seems so simple and yet today, most of these products we use have been tainted with some chemical, potentially harmful in one way or another. BotanoCap's work will help change this by achieving the same ultimate deliverable but safely and naturally. It is a worldwide unmet need and we are happy to support initiatives that strive to make the world a cleaner, greener and safer place to live," said Amir Gal-Or, founding and managing partner at Infinity Group. 

"The investment announced today reflects the confidence Infinity Gr
'/>"/>

SOURCE Infinity Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
2. New 2 Hour Educational Learning Labs at MD&M West Will Feature Baxter Bioscience, BMW, Dell, GE Healthcare, Mattel, Northrup Grumman, Starbucks and Other Leading Groups in Design, Manufacturing, Engineering and Automation
3. PAI Medical Group Brings Revolutionary ARTAS Robotic System to Nashville
4. Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer
5. MiMedx Group Announces Proposed Public Offering of Common Stock
6. 22nd Century Group, Inc. CEO to Webcast, Live, at RetailInvestorConferences.com on December 5th
7. Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
8. Everest Group Recognizes TCS as a Global Leader and Star Performer in Life Sciences IT Outsourcing
9. Strategic Alliance With Dr. Narain Naidu and the Naidu Group of Companies Announced by ASEA, LLC
10. Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting
11. IPO, Earnings & Corporate Developments: Twitter, Vale SA, OCZ Technology Group, Radian Group, Keryx Biopharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Pipette.com has added ... to their comprehensive portfolio of Eppendorf products. , The ... purchase a Centrifuge 5424/5424 R and receive the following:, ... Eppendorf Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Geneva, Switzerland (PRWEB) January 22, 2015 ... for characterized mammalian Research Cell Banks (RCBs) used for ... generated Research Cell Banks will include Next-Generation Sequencing ... cell’s genetic architecture de-risks biologic manufacturing by ensuring the ...
(Date:1/22/2015)... Calif. , Jan. 22. 2015  Varian Medical Systems (NYSE: ... software, has been honored for its commitment to sustainability with ... companies. Varian is the highest ranked healthcare equipment company among ... today during the World Economic Forum at Davos, ...
(Date:12/24/2014)... SPRING, Md. , Dec. 24, 2014  United Therapeutics ... Medtronic, Inc. (NYSE: MDT ) has submitted ... Drug Administration (FDA) for the use of Medtronic,s SynchroMed ... newly developed catheter) for use with United Therapeutics, Remodulin ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... to rule the world, the honey bee, Apis mellifera, ... demonstrates that when these honey bees arrive in a ... from the genetic endowment of their predecessors. , ... in Proceedings of the National Academy of Sciences. , ...
... Thermo Fisher,Scientific Inc. (NYSE: TMO ), the ... press conference on Monday, March 3, 2008, at,12:30 p.m. ... be held this year in New Orleans., Marc ... provide an overview of the company, and Dr. Ian ...
... $160 million or more, up from $42 ... - First HGS product sales expected with delivery of ABthrax(TM) to ... - First Albuferon(R) Phase 3 data expected late 2008 -, - Enrollment completed ... ...
Cached Biology Technology:Honey bee invaders exploit the genetic resources of their predecessors 2Honey bee invaders exploit the genetic resources of their predecessors 3Thermo Fisher Scientific to Webcast Press Conference at PITTCON 2008 2Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 2Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 3Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 4Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 5Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 6Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 7Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 8Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 9Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 10Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress 11
(Date:12/19/2014)... LaunchKey , the first decentralized mobile authentication and authorization ... era, today announced the close of $3 million in ... Metamorphic Ventures with participation from ENIAC Ventures, Crosslink Capital, ... has raised $4 million to date, and will use ...
(Date:12/17/2014)... DUBLIN , Dec. 16, 2014 Research and Markets ... of the "Global Chemical Sensor Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 One major trend upcoming in ... in biomedical applications. Chemical sensors help in recording of ...
(Date:12/11/2014)... SALEM, N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... Ore. Wildfire, insect outbreaks and hurricanes destroy huge ... of carbon dioxide entering the atmosphere, but scientists are ... affect their climate impact. Researchers conclude in a ... amount of energy reflected back into space, is important ...
... Researchers at Case Western Reserve University School of Medicine ... to two weeks after donor death work as well as ... National Eye Institute has awarded a $12.3 million grant to ... nationwide meets current needs about 40,000 transplants in 2010. ...
... (Boston) The National Institutes of Health (NIH) ... and the College of Engineering (COE) a five ... Caroline Genco, PhD, research director, Section of Infectious ... is the principal investigator alongside Selim nl, PhD, ...
Cached Biology News:'Albedo effect' in forest disturbances can cause added warming, bonus cooling 2'Albedo effect' in forest disturbances can cause added warming, bonus cooling 3Study seeks to widen corneal transplant window 2Study seeks to widen corneal transplant window 3NIH training grant awarded to Boston University School of Medicine and College of Engineering 2
Anti-Mouse Reticular Fibroblast, Purified (Clone ER-TR7) (rat IgG2a)...
...
...
... isomers are predominantly used for labeling proteins, ... labeling peptides and nucleotides because they give ... often required in the conjugation processes. 5-TAMRA ... labeling peptides and proteins. 6-TAMRA is predominately ...
Biology Products: